IOBIndian Overseas Bank

Indian Overseas Bank's Q2 profit rises 55.9% to ₹1,912 crore; gross NPA 1.19%

Indian Overseas Bank's September-quarter standalone profit was ₹1,912.42 crore against ₹1,226.42 crore a year earlier. Gross NPA was 1.19% and net NPA 0.16%.

Price, Monday's close₹30.38▲ 5.93%
Last 5 days
52-week low ₹28.3252-week high ₹41.80
Sector
Public sector banking

What happened

  • Indian Overseas Bank reported standalone net profit of ₹1,912.42 crore for the September 2026 quarter against ₹1,226.42 crore a year earlier, up 55.9%, Kotak Neo and Indian Masterminds reported. First-half profit was ₹3,571.66 crore against ₹2,337.46 crore.
  • Indian Masterminds gave net interest income as ₹3,866.98 crore, up 26.4%, and operating profit as ₹3,016.49 crore, up 25.7%. Advances rose 25% to ₹3,42,061 crore and deposits 20% to ₹4,07,428 crore, it said.
  • Gross non-performing assets were 1.19% of advances and net NPAs 0.16%, both outlets reported. Kotak Neo gave the provision coverage ratio as 97.69%. Both gave the capital adequacy ratio as 18.60%. The outlets differ on the year-earlier gross NPA ratio, so it is not given here.
  • The shares closed at ₹30.38 against ₹28.68 on Friday on Kite data, a rise of 5.93% by my calculation, after trading between ₹28.32 and ₹30.52. Kotak Neo's report is timed at 4:05 PM.

Why it matters

Good to know: Provision coverage ratio is the share of a bank's bad loans for which it has already set aside money. At 97.69%, almost the whole of the bank's non-performing balance is covered, which is why net NPA (0.16%) is so much lower than gross NPA (1.19%).

Key facts

Standalone net profit
₹1,912.42 crore (₹1,226.42 crore a year earlier), up 55.9%
Net interest income, per Indian Masterminds
₹3,866.98 crore, up 26.4%
Gross / net NPA
1.19% / 0.16%
Advances / deposits
₹3,42,061 crore, up 25% / ₹4,07,428 crore, up 20%
Capital adequacy ratio
18.60%

Read the source

This is a summary of public news about Indian Overseas Bank, for information only. It is not a recommendation to buy, sell or hold IOB.

Next story · 4 of 6Mankind Pharma · MANKINDMankind Pharma's Q2 profit rises 38-39% to about ₹711-716 crore; revenue up 17.3%